|
1
|
De Rossi SS and Ciarrocca K: Oral lichen
planus and lichenoid mucositis. Dent Clin North Am. 58:299–313.
2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Popovska M, Radojkova-Nikolovska V,
Minovska A, Agop Forna D, Muratovska I and Forna NC: Etiopathogenic
biochemical mechanism involved in oral lichen planus. Rev Chim.
66:1786–1790. 2015.
|
|
3
|
Ianosi SL, Forsea AM, Lupu M, Ilie MA,
Zurac S, Boda D, Ianosi G, Neagoe D, Tutunaru C, Popa CM and
Caruntu C: Role of modern imaging techniques for the in vivo
diagnosis of lichen planus. Exp Ther Med. 17:1052–1060.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lupu M, Caruntu A, Caruntu C, Boda D,
Moraru L, Voiculescu V and Bastian A: Non-invasive imaging of
actinic cheilitis and squamous cell carcinoma of the lip. Mol Clin
Oncol. 8:640–646. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lupu M, Căruntu A, Moraru L, Voiculescu
VM, Boda D, Tanase C and Căruntu C: Non-invasive imaging techniques
for early diagnosis of radiation-induced squamous cell carcinoma of
the lip. Rom J Morphol Embryol. 59:949–953. 2018.PubMed/NCBI
|
|
6
|
Calenic B, Greabu M, Caruntu C, Nicolescu
MI, Moraru L, Surdu-Bob CC, Badulescu M, Anghel A, Logofatu C and
Boda D: Oral keratinocyte stem cells behavior on diamond like
carbon films. Rom Biotechnol Lett. 21:11914–11922. 2016.
|
|
7
|
Boda D, Docea AO, Calina D, Ilie MA,
Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE,
Voiculescu V, et al: Human papilloma virus: Apprehending the link
with carcinogenesis and unveiling new research avenues. Int J
Oncol. 52:637–655. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Boda D, Neagu M, Constantin C, Voinescu
RN, Caruntu C, Zurac S, Spandidos DA, Drakoulis N, Tsoukalas D and
Tsatsakis AM: HPV strain distribution in patients with genital
warts in a female population sample. Oncol Lett. 12:1779–1782.
2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Solomon I, Voiculescu VM, Caruntu C, Lupu
M, Popa A, Ilie MA, Albulescu R, Caruntu A, Tanase C, Constantin C,
et al: Neuroendocrine factors and head and neck squamous cell
carcinoma: An affair to remember. Dis Markers.
2018(9787831)2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Giuliani M, Troiano G, Cordaro M,
Corsalini M, Gioco G, Lo Muzio L, Pignatelli P and Lajolo C: Rate
of malignant transformation of oral lichen planus: A systematic
review. Oral Dis. 25:693–709. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Aniyan KY, Guledgud MV and Patil K:
Alterations of serum lipid profile patterns in oral lichen planus
patients: A case-control study. Contemp Clin Dent. 9 (Suppl
1):S112–S121. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sezer E, Ozugurlu F, Ozyurt H, Sahin S and
Etikan I: Lipid peroxidation and antioxidant status in lichen
planus. Clin Exp Dermatol. 32:430–434. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lai YC, Yew YW and Schwartz RA: Lichen
planus and dyslipidemia: A systematic review and meta-analysis of
observational studies. Int J Dermatol. 55:e295–e304.
2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ozbagcivan O, Akarsu S, Semiz F and Fetil
E: Comparison of serum lipid parameters between patients with
classic cutaneous lichen planus and oral lichen planus. Clin Oral
Investig. 24:719–725. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Arias-Santiago S, Eisman AB, Fernandez JA,
Girón-Prieto MS, Gutiérrez-Salmerón MT, García Mellado V and
Naranjo-Sintes R: Cardiovascular risk factors in patients with
lichen planus. Am J Med. 124:543–548. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Esteve E, Ricart W and Fernández-Real JM:
Dyslipidemia and inflammation: An evolutionary conserved mechanism.
Clin Nutr. 24:16–31. 2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Krishnamoorthy B, Suma GN, Mamatha NS,
Sowbhagya MB and Komali Garlapati: Lipid profile and metabolic
syndrome status in patients with oral lichen planus, oral lichenoid
reactions and healthy individuals attending a dental college in
Northern India - a descriptive study. J Clin Diagn Res.
8:ZC92–ZC95. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hotamisigil GS: Inflammation and metabolic
disorders. Nature. 444:860–867. 2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Scheller J, Chalaris A, Schmidt-Aras D and
Rose-John S: The pro- and anti-inflammatory properties of the
cytokine interleukin-6. Biochim Biophys Act. 1813:878–888.
2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xing Z, Gauldie J, Cox G, Baumann H,
Jordana M, Lei XF and Achong MK: IL6 is an antiinflammatory
cytokine required for controlling local or systemic acute
inflammatory responses. J Clin Invest. 101:311–320. 1998.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Paquet P and Piérard GE: Interleukin-6 and
the skin. Int Arch Allergy Immunol. 109:308–317. 1996.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lipsky PE: Interleukin-6 and rheumatic
diseases. Arthritis Res Ther. 8 (Suppl 2)(S4)2006.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Khishimoto T: Interleukin-6: Discovery of
a pleiotropic cytokine. Arthritis Res Ther. 8 (Suppl
2)(S2)2006.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Patil S, Roopa SR, Sanketh DS, Sarode SC
and Sarode GS: A universal diagnostic criteria for oral lichen
planus: An exigency! Int J Contemp Dental Medical Rev. 1–4.
2014.
|
|
25
|
Baykal L, Arıca DA, Yaylı S, Örem A,
Bahadır S, Altun E and Yaman H: Prevalence of metabolic syndrome in
patients with lichen planus. A case-control study. Am J Clin
Dermatol. 16:439–445. 2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Romero MA, Seoane J, Varela-Centelles P,
Diz-Dios P and Garcia-Pola MJ: Prevalence of diabetes mellitus
amongst oral lichen planus patients. Clinical and pathological
characteristics. Med Oral. 7:121–129. 2002.PubMed/NCBI(In English, Spanish).
|
|
27
|
Eisen D: The clinical features, malignant
potential and systemic associations of oral lichen planus: A study
of 723 patients. J Am Acad Dermatol. 46:207–214. 2002.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lopez-Jornet P, Alonso CF and
Rodríguez-Martines MA: Alterations in serum lipid profile patterns
in oral lichen planus. A cross-sectional study. Am J Clin Dermatol.
13:399–404. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Neimann AL, Shin DB, Wang X, Margolis DJ,
Troxel AB and Gelfand JM: Prevalence of cardiovascular risk factors
in patients with psoriasis. J Am Acad Dermatol. 55:829–835.
2006.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sommer DM, Jenish S, Suchan M,
Christophers E and Weichenthal M: Increased prevalence of the
metabolic syndrome in patients with moderate to severe psoriasis.
Arch Dermatol Res. 298:321–328. 2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Grechin C, Solovăstru LG, Vâță D, Pătrașcu
AI, Grăjdeanu AI and Porumb-Andrese E: Inflammatory marker
alteration in response to systemic therapies in psoriasis. Exp Ther
Med. 20:42–46. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Boda D and Dehelean C:
Immuno-dermatological processes involved in chronic skin diseases:
Highlights of the Second Conference of the Romanian Society for
Immuno-Dermatology, Bucharest. Exp Ther Med. 18:873–874.
2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Narazaki M and Kishimoto T: The two-faced
cytokine IL-6 in host defenseand diseases. Int J Mol Sci.
19(3528)2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Pauli N, Puchałowicz K, Kuligowska A,
Krzystolik A, Dziedziejko V, Safranow K, Rać M, Chlubek D and Rać
ME: Associations between IL-6 and echo-parameters in patients with
early onset coronary artery disease. Diagnostics (Basel).
9(189)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gabay C: Interleukin-6 and chronic
inflammation. Arthritis Res Ther. 8 (Suppl 2)(S3)2006.PubMed/NCBI View
Article : Google Scholar
|
|
36
|
Tanaka T, Narazaki M, Masuda K and
Kishimoto T: Interleukin-6: Pathogenesis and treatment of
autoimmune inflammatory diseases. Inflam Regeneratin. 33:54–65.
2013.
|
|
37
|
Tanaka T, Narazaki M and Kishimoto T:
Therapeutic targeting of interleukin-6 receptor. Ann Rev Pharmacol
Toxicol. 52:199–219. 2012.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wallenius V, Wallenius K, Ahrén B, Rudling
M, Carlsten H, Dickson SL, Ohlsson C and Jansson JO: Interleukin-6
deficient mice develop mature-onset obesity. Nat Med. 8:75–79.
2002.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Matthews VB, Allen TL, Risis S, Chan MH,
Henstridge DC, Watson N, Zaffino LA, Babb JR, Boon J, Meikle PJ, et
al: Interleukin-6-deficient mice develop hepatic inflammation and
systemic insulin resistance. Diabetologia. 53:2431–2441.
2010.PubMed/NCBI View Article : Google Scholar
|
